Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 50129 

data. You may submit comments on any 

topic related to this activity. Comments 

received, including attachments and 

other supporting materials, are part of 

the public record and subject to public 

disclosure. Do not include any 

information in your comment or 

supporting materials that you consider 

confidential or inappropriate for public 

disclosure. If you include your name, 

contact information, or other 

information that identifies you in the 

body of your comments, that 

information will be on public display. 

CDC will review all submissions and 

may choose to redact, or withhold, 

submissions containing private or 

proprietary information such as Social 

Security numbers, medical information, 

inappropriate language, or duplicate/ 

near duplicate examples of a mass-mail 

campaign. CDC will carefully consider 

all comments submitted into the docket. 

CDC does not accept comment by email. 

Oral Public Comment: The public is 

welcome to participate, via Zoom, 

during the public comment periods on 

September 28, 2021, from 11:30 a.m. to 

12:00 p.m., EDT, and on September 29, 

2021, from 12:10 p.m. to 12:40 p.m., 

EDT. Please note that the public 

comment periods end at the times 

indicated above. Each commenter will 

be provided up to five minutes for 

comment. A limited number of time 

slots are available and will be assigned 

on a first come-first served basis. 

Members of the public who wish to 

address the WTCHP STAC during the 

oral public comment sessions must sign 

up by providing their name and desired 

date for commenting to Mia Wallace, 

Committee Management Specialist, via 

email: MWallace@cdc.gov, or the 

addresses section provided in this 

notice by September 21, 2021. 

Written Public Comment: Written 

comments will also be accepted from 

those unable to attend the public 

session per the instructions provided in 

the addresses section above. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. Written 

comments received by September 21, 

2021 will be provided to the STAC prior 

to the meeting. The docket will close on 

September 29, 2021. 

Policy on Redaction of Committee 

Meeting Transcripts (Public Comment): 

Transcripts will be prepared and posted 

to http://www.regulations.gov within 60 

days after the meeting. If a person 

making a comment gives their name, no 

attempt will be made to redact that 

name. NIOSH will take reasonable steps 

to ensure that individuals making 

public comments are aware that their 

comments (including their name, if 

provided) will appear in a transcript of 

the meeting posted on a public website. 

Such reasonable steps include a 

statement read at the start of the meeting 

stating that transcripts will be posted, 

and names of speakers will not be 

redacted. If individuals in making a 

statement reveal personal information 

(e.g., medical information) about 

themselves, that information will not 

usually be redacted. The CDC Freedom 

of Information Act coordinator will, 

however, review such revelations in 

accordance with the Freedom of 

Information Act and, if deemed 

appropriate, will redact such 

information. Disclosures of information 

concerning third party medical 

information will be redacted. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–19224 Filed 9–3–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Membership on the Lead Exposure and 

Prevention Advisory Committee 

(LEPAC) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is 

soliciting nominations for membership 

on the LEPAC. The LEPAC is composed 

of 15 members that are Federal and nonFederal experts in fields associated with 

lead screening, the prevention of lead 

exposure, and services for individuals 

and communities affected by lead 

exposure. Nominations are being sought 

for individuals with expertise in the 

fields of epidemiology, toxicology, 

mental health, pediatrics, early 

childhood education, special education, 

diet and nutrition, and environmental 

health. Members may be invited to serve 

for three-year terms. Selection of 

members is based on candidates’ 

qualifications to contribute to the 

accomplishment of LEPAC objectives. 

DATES: Nominations for membership on 

the LEPAC must be received no later 

than November 1, 2021. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

emailed to LEPAC@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: Paul 

Allwood, Ph.D., M.P.H., Designated 

Federal Officer, National Center for 

Environmental Health, CDC, 4770 

Buford Highway NE, Atlanta, GA 

30329–4018, Telephone: (770) 488– 

6774, PAllwood@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

members of this committee are selected 

by the Secretary of the U.S. Department 

of Health and Human Services (HHS). 

The committee’s objective is to advise 

the Secretary, HHS and the Director, 

Centers for Disease Control and 

Prevention/Administrator, Agency for 

Toxic Substances and Disease Registry 

on a range of activities to include: (1) 

Review of Federal programs and 

services available to individuals and 

communities exposed to lead; (2) review 

of the current research on lead exposure 

to identify additional research needs;(3) 

review of and identification of best 

practices, or the need for best practices 

regarding lead screening and the 

prevention of lead exposure; (4) 

identification of effective services, 

including services relating to healthcare, 

education, and nutrition for individuals 

and communities affected by lead 

exposure and lead poisoning, including 

in consultation with, as appropriate, the 

lead exposure registry as established in 

Public Law 114–322 Section 2203(b) (42 

U.S.C. 300j-27); and (5) undertaking of 

any other review or activities that the 

Secretary determines to be appropriate. 

Annually as determined necessary by 

the Secretary or as required by Congress, 

the committee shall submit a report to 

include: (1) An evaluation of the 

effectiveness of the Federal programs 

and services available to individuals 

and communities exposed to lead; (2) an 

evaluation of additional lead exposure 

research needs; (3) an assessment of any 

effective screening methods or best 

practices used or developed to prevent 

or screen for lead exposure; (4) input 

and recommendations for improved 

access to effective services relating to 

health care, education, or nutrition for 

individuals and communities impacted 

by lead exposure; and (5) any other 

recommendations for communities 


sradovich on DSKJLST7X2PROD with NOTICES
50130 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 

affected by lead exposure, as 

appropriate. 

At least half of the committee will 

consist of Federal representatives from a 

range of agencies that may include the 

Department of Housing and Urban 

Development; the Environmental 

Protection Agency; the Consumer 

Product Safety Commission; the Centers 

for Medicare and Medicaid Services; the 

Health Resources and Services 

Administration; the Food and Drug 

Administration; the U.S. Department of 

Agriculture; the Occupational Safety 

and Health Administration; the National 

Institute of Environmental Health 

Sciences; the U.S. Geological Survey; 

and such additional federal, state, tribal, 

and local public and private officials as 

the Secretary deems necessary for the 

committee to carry out its function. The 

rest of the committee will consist of 

non-Federal members. Only non-Federal 

members are being solicited with this 

announcement. 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented, and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. 

Committee members are Special 

Government Employees, requiring the 

filing of financial disclosure reports at 

the beginning and annually during their 

terms. CDC reviews potential candidates 

for LEPAC membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment as soon 

as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. Candidates should 

submit the following items: 

• Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

• At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.) 

Nominations may be submitted by the 

candidate him- or herself or by the 

person/organization recommending the 

candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–19222 Filed 9–3–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0929] 

Food and Drug Administration New Era 

of Smarter Food Safety Summit on ECommerce; Public Meeting; Request 

for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public meeting; 

request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing a virtual public meeting 

entitled ‘‘FDA New Era of Smarter Food 

Safety Summit on E-Commerce: 

Ensuring the Safety of Foods Ordered 

Online and Delivered Directly to 

Consumers.’’ The purpose of the public 

meeting is to engage with stakeholders 

and invite input on various topics 

pertaining to the implementation of 

Core Element 3.1 of the New Era of 

Smarter Food Safety Blueprint. We 

intend to use information resulting from 

the public meeting to determine what 

action(s), if any, should be taken to help 

ensure the safe production and delivery 

of human and animal foods sold 

through new e-commerce business 

models. 

DATES: The public meeting will be held 

over 3 days on October 19, 2021, from 

11:30 a.m. to 5:30 p.m. Eastern Time; 

October 20, 2021, from 11:30 a.m. to 

5:15 p.m. Eastern Time, and October 21, 

2021, from 11:30 a.m. to 3:45 p.m. 

Eastern Time. Submit either electronic 

or written comments on this public 

meeting by November 20, 2021. See 

‘‘Participating in the Public Meeting’’ in 

the SUPPLEMENTARY INFORMATION section 

of this document for registration and 

other information regarding meeting 

participation. 

ADDRESSES: The public meeting will be 

held virtually. For more information on 

the public meeting, see: https://

www.fda.gov/food/workshops-meetingswebinars-food-and-dietarysupplements/new-era-smarter-foodsafety-summit-e-commerce-ensuringsafety-foods-ordered-online-anddelivered. 

You may submit comments as 

follows. Please note that late, untimely 

filed comments will not be considered. 

Electronic comments must be submitted 

on or before November 20, 2021. The 

https://www.regulations.gov electronic 

filing system will accept comments 

until 11:59 p.m. Eastern Time at the end 

of November 20, 2021. Comments 

received by mail/hand delivery/courier 

(for written/paper submissions) will be 

considered timely if they are 

postmarked or the delivery service 

acceptance receipt is on or before that 

date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 


sradovich on DSKJLST7X2PROD with NOTICES